'You Can See Everything' Surpasses $100 Million at Global Box Office
The Elizabeth Holmes documentary 'You Can See Everything' has crossed $100 million at the worldwide box office, marking an exceptionally rare theatrical milestone driven by $93.4 million in domestic ticket sales.

In this piece
The Theranos documentary 'You Can See Everything' has surpassed $100 million worldwide, reaching a rare box office milestone for non-fiction cinema. Driven by…
The feature documentary “You Can See Everything” has officially crossed the $100 million mark at the worldwide box office, securing a rare commercial milestone for non-fiction cinema. According to reporting from Variety, the film examining convicted Theranos founder Elizabeth Holmes has reached a cumulative global gross of $102.4 million. The accomplishment places the project into an elite tier of theatrical documentaries that have managed to translate specialized subject matter into mainstream theatrical success.
The bulk of the film's ticket sales has been generated in the domestic market, where it has amassed a staggering $93.4 million to date. International audiences have contributed an additional $9 million from overseas territories, rounding out its nine-figure global haul. The wide disparity between North American receipts and international returns highlights the intense domestic interest that has surrounded the high-profile corporate scandal.
At the center of the film is the dramatic rise and fall of Elizabeth Holmes, the Silicon Valley entrepreneur whose blood-testing startup Theranos collapsed amid widespread fraud. Holmes, who claimed to have revolutionized medical diagnostics before regulatory scrutiny and investigative reporting unraveled the deception, has remained a fixture of intense public fascination. The documentary captures that cultural zeitgeist, turning an intricate tale of executive deception and venture capital excess into a compelling narrative for cinema audiences.
Reaching $100 million is an extraordinary feat for any non-fiction release, a category historically constrained by niche audiences and modest theatrical distribution. While blockbuster fictional releases frequently measure success in hundreds of millions, theatrical documentaries seldom break out beyond festival circuits and limited platform releases. The milestone achieved by “You Can See Everything” reflects an uncommon alignment of audience appetite, compelling subject material, and broad theatrical reach.
Industry observers attribute much of this commercial velocity to the ongoing public appetite for stories exploring high-stakes corporate misconduct. The Theranos saga encapsulates themes of ambition, deception, and the perils of unchecked hype within the technology sector. By presenting a focused examination of Holmes and the fallout of her fraudulent enterprise, the production appears to have tapped directly into the broader cultural dialogue surrounding institutional accountability.
The domestic total of $93.4 million underscores an exceptional level of sustained moviegoer turnout across North American cinemas. For a non-fiction title, achieving ticket sales of that magnitude typically requires strong word-of-mouth recommendations and repeat viewings extending well beyond traditional documentary enthusiasts. The momentum demonstrates that moviegoers remain willing to purchase theater tickets for non-fiction storytelling when the subject captures the national conversation.
While the international gross stands at a more modest $9 million, overseas performance continues to contribute to the project's bottom line. Non-fiction features often face uneven distribution patterns internationally, where marketing campaigns and release windows differ markedly from domestic rollouts. Even with a smaller footprint abroad, reaching global distribution and crossing the nine-figure threshold highlights the international resonance of the American business scandal.
As Variety noted, the film continues to generate steady revenue as its theatrical run unfolds. The production's commercial trajectory demonstrates that documentary filmmaking can still command significant box office power in an evolving theatrical landscape. With additional box office tallies still accumulating, the project stands as a prominent case study in how compelling real-world drama can achieve historic commercial heights.
Primary source: Variety. Newzly rewrites and structures source reporting for clarity; verify critical details at the original.